CRM1, an RNA transporter, is a major species-specific restriction factor of human T cell leukemia virus type 1 (HTLV-1) in rat cells

Microbes and Infection

Volumn 8, Issue 3, 2006, Pages 851-859

  Zhang, Xianfeng ^a   Hakata, Yoshiyuki ^a   Tanaka, Yuetsu ^b   Shida, Hisatoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

CRM1; Human T cell leukemia virus type 1; Species barrier

Indexed keywords

EXPORTIN 1; GAG PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL FUSION; CELL GROWTH; CELL LINE; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; RNA TRANSPORT; SPECIES DIFFERENCE; TRANSGENIC ANIMAL; VIRION; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE;

ADENOCARCINOMA; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL FUSION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; KARYOPHERINS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SPECIES SPECIFICITY; VIRAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 33646066870     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.10.009     Document Type: Article

References (50)

1. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., Shirakawa S., and Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 6476-6480
2. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., and Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1 (1986) 1031-1032
3. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86 (1995) 3619-3639
4. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19 (2001) 475-496
5. Hidaka M., Inoue J., Yoshida M., and Seiki M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7 (1988) 519-523
6. Cullen B.R. Regulation of human immunodeficiency virus replication. Annu. Rev. Microbiol. 45 (1991) 219-250
7. Inoue J., Yoshida M., and Seiki M. Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3653-3657
8. Ballaun C., Farrington G.K., Dobrovnik M., Rusche J., Hauber J., and Bohslein E. Functional analysis of human T-cell leukemia virus type I rex-response element: direct RNA binding of Rex protein correlates with in vivo activity. J. Virol. 65 (1991) 4408-4413
9. Bogerd H.P., Huckaby G.L., Ahmed Y.F., Hanly S.M., and Greene W.C. The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5704-5708
10. Fornerod M., Ohno M., Yoshida M., and Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90 (1997) 1051-1060
11. Hakata Y., Umemoto T., Matsushita S., and Shida H. Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of human T-cell leukemia virus type 1. J. Virol. 72 (1998) 6602-6607
12. Nemergut M.E., Lindsay M.E., Brownawell A.M., and Macara I.G. Ran-binding protein 3 links Crm1 to the Ran guanine nucleotide exchange factor. J. Biol. Chem. 277 (2002) 17385-17388
13. Bogerd H., and Greene W.C. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J. Virol. 67 (1993) 2496-2502
14. Shida H., and Hakata Y. Multiple roles of cellular export machinery in HTLV-1 Rex functioning. Gann monogr. 50 (2003) 61-72
15. Shida H., Tochikura T., Sato T., Konno T., Hirayoshi K., Seki M., Ito Y., Hatanaka M., Hinuma Y., Sugimoto M., et al. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J. 6 (1987) 3379-3384
16. Ogawa K., Matsuda S., and Seto A. Induction of leukemic infiltration by allogeneic transfer of HTLV-I-transformed T cells in rabbits. Leuk. Res. 13 (1989) 399-406
17. Tanaka Y., Tanaka R., Terada E., Koyanagi Y., Miyano-Kurosaki N., Yamamoto N., Baba E., Nakamura M., and Shida H. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J. Virol. 68 (1994) 6323-6331
18. Kazanji M., Ureta-Vidal A., Ozden S., Tangy F., de Thoisy B., Fiette L., Talarmin A., Gessain A., and de G. The Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses. J. Virol. 74 (2000) 4860-4867
19. McGinn T.M., Wei Q., Stallworth J., and Fultz P.N. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques. AIDS Res. Hum. Retroviruses 20 (2004) 443-456
20. Ibuki K., Funahashi S.I., Yamamoto H., Nakamura M., Igarashi T., Miura T., Ido E., Hayami M., and Shida H. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene. J. Gen. Virol. 78 Pt 1 (1997) 147-152
21. Feng R., Kabayama A., Uchida K., Hoshino H., and Miwa M. Cell-free entry of human T-cell leukemia virus type 1 to mouse cells. Jpn. J. Cancer Res. 92 (2001) 410-416
22. Denesvre C., Sonigo P., Corbin A., Ellerbrok H., and Sitbon M. Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes. J. Virol. 69 (1995) 4149-4157
23. Nagy K., Clapham P., Cheingsong-Popov R., and Weiss R.A. Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int. J. Cancer 32 (1983) 321-328
24. Sun B., Nitta T., Shoda M., Tanaka M., Hanai S., Hoshino H., and Miwa M. Cell-free human T-cell leukemia virus type 1 binds to, and efficiently enters mouse cells. Jpn. J. Cancer Res. 93 (2002) 760-766
25. Ibrahim F., Fiette L., Gessain A., Buisson N., de-The G., and Bomford R. Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location. Int. J. Cancer 58 (1994) 446-451
26. Suga T., Kameyama T., Kinoshita T., Shimotohno K., Matsumura M., Tanaka H., Kushida S., Ami Y., Uchida M., Uchida K., et al. Infection of rats with HTLV-1: a small-animal model for HTLV-1 carriers. Int. J. Cancer 49 (1991) 764-769
27. Ishiguro N., Abe M., Seto K., Sakurai H., Ikeda H., Wakisaka A., Togashi T., Tateno M., and Yoshiki T. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J. Exp. Med. 176 (1992) 981-989
28. Kasai T., Ikeda H., Tomaru U., Yamashita I., Ohya O., Morita K., Wakisaka A., Matsuoka E., Moritoyo T., Hashimoto K., Higuchi I., Izumo S., Osame M., and Yoshiki T. A rat model of human T lymphocyte virus type I (HTLV-I) infection: in situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy. Acta. Neuropathol. (Berl) 97 (1999) 107-112
29. Li Q.X., Camerini D., Xie Y., Greenwald M., Kuritzkes D.R., and Chen I.S. Syncytium formation by recombinant HTLV-II envelope glycoprotein. Virology 218 (1996) 279-284
30. Sutton R.E., and Littman D.R. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70 (1996) 7322-7326
31. Okuma K., Nakamura M., Nakano S., Niho Y., and Matsuura Y. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology 254 (1999) 235-244
32. Manel N., Kim F.J., Kinet S., Taylor N., Sitbon M., and Battini J.L. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115 (2003) 449-459
33. Hakata Y., Yamada M., and Shida H. Rat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells. J. Virol. 75 (2001) 11515-11525
34. Hakata Y., Yamada M., and Shida H. A multifunctional domain in human CRM1 (exportin 1) mediates RanBP3 binding and multimerization of human T-cell leukemia virus type 1 Rex protein. Mol. Cell. Biol. 2 (2003) 8751-8761
35. Callanan M., Kudo N., Gout S., Brocard M., Yoshida M., Dimitrov S., and Khochbin S. Developmentally regulated activity of CRM1/XPO1 during early Xenopus embryogenesis. J. Cell Sci. 113 Pt 3 (2000) 451-459
36. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 (2004) 848-853
37. Sheehy A.M., Gaddis N.C., Choi J.D., and Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 (2002) 646-650
38. Derse D., Hill S.A., Lloyd P.A., Chung H., and Morse B.A. Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J. Virol. 75 (2001) 8461-8468
39. Fan N., Gavalchin J., Paul B., Wells K.H., Lane M.J., and Poiesz B.J. Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I. J. Clin. Microbiol. 30 (1992) 905-910
40. Onishi M., Kinoshita S., Morikawa Y., Shibuya A., Phillips J., .Lanier L.L., Gorman D.M., Nolan G.P., Miyajima A., and Kitamura T. Application of retrovirus-mediated expression cloning. Exp. Hematol. 24 (1996) 324-329
41. Fujisawa J., Seiki M., Kiyokawa T., and Yoshida M. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 2277-2281
42. Tanaka Y., Yasumoto M., Nyunoya H., Ogura T., Kikuchi M., Shimotohno K., Shiraki H., Kuroda N., Shida H., and Tozawa H. Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I). Int. J. Cancer 46 (1990) 675-681
43. Tanaka Y., Zeng L., Shiraki H., Shida H., and Tozawa H. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J. Immunol. 147 (1991) 354-360
44. Koya Y., Ohashi T., Kato H., Hanabuchi S., Tsukahara T., Takemura F., Etoh K., Matsuoka M., Fujii M., and Kannagi M. Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax. J. Virol. 73 (1999) 6436-6443
45. Yamamoto N., Okada M., Koyanagi Y., Kannagi M., and Hinuma Y. Transformation of human leukocytes by cocultivation with an adult T cell leukemia Virus producer cell line. Science 217 (1982) 737-739
46. Popovic M., Sarin P.S., Robert-Gurroff M., Kalyanaraman V.S., Mann D., Minowada J., and Gallo R.C. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 219 (1983) 856-859
47. Delamarre L., Rosenberg A.R., Pique C., Pham D., and Dokhelar M.C. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J. Virol. 71 (1997) 259-266
48. Jassal S.R., Lairmore M.D., Leigh-Brown A.J., and Brighty D.W. Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells. Virus. Res. 78 (2001) 17-34
49. Hildreth J.E., Subramanium A., and Hampton R.A. Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology. J. Virol. 71 (1997) 1173-1180
50. Daenke S., McCracken S.A., and Booth S. Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7. J. Gen. Virol. 80 Pt 6 (1991) 429-436